GLP-1 patient questions, answered
180 questions people ask in patient forums, grouped into 18 topics. Each answer comes from trial data or the FDA label, with the PubMed citation beside it.
The 10 Tirzepatide Questions People Actually Ask, Answered From the Trials
Ten questions patients keep asking about tirzepatide on Reddit (will it come back, does it stop working, why am I starving on day 6), answered from SURMOUNT, SURPASS, SUMMIT and SYNERGY-NASH.
10 questions · checked May 2026
Semaglutide Side Effects: 10 Questions, Answered From the Trials
How long the nausea lasts, why the burps smell, what the gallbladder and hair-loss data actually say, whether the suicidality signal held up, and when a symptom stops being something to wait out.
10 questions · checked May 2026
Compounded or Brand: the 10 Questions Patients Keep Asking
No trial has ever compared a compounded GLP-1 against Wegovy, Ozempic, Mounjaro or Zepbound. Here is what the record does show on potency, sterility tiers, dosing errors, legality after the shortages, and what switching actually involves.
10 questions · checked May 2026
GLP-1 Coverage: the 10 Questions People Ask After a Denial
What a prior authorization actually requires, why an approval can still leave a $600 copay, what Medicare and Medicaid will and will not pay for, and which appeal arguments have worked, with the label and trial evidence behind each.
10 questions · checked May 2026
Oral GLP-1s: 10 Questions About Rybelsus, the Wegovy Pill and Foundayo
Why the fasting rule exists, what a pill actually delivers against an injection, how the new 25 mg Wegovy tablet differs from Rybelsus, and what Foundayo's approved dose ladder really is, with the trial numbers behind each.
10 questions · checked May 2026
Injecting a GLP-1: 10 Technique Questions, Answered
Whether the site changes anything, when to pinch, why one week stings more than the last, what the hard lump is, and which of these actually matters, from the labels and the injection-technique evidence.
10 questions · checked May 2026
GLP-1 Plateaus: 10 Questions About Why the Scale Stopped
What the trial curves actually do at month six, whether a stall means the drug quit, when a dose step helps, and how long a plateau normally runs before it breaks.
10 questions · checked May 2026
GLP-1 Hair Loss: 10 Questions, and What the Evidence Supports
Whether it grows back, whether it is the drug or the weight loss, when the shed starts and ends, which supplements have evidence behind them, and whether slowing down actually helps.
10 questions · checked May 2026
GLP-1s and Alcohol: 10 Questions About Why Drinking Changed
Why the desire to drink often disappears, why tolerance drops and hangovers get worse, whether it is safe to drink at all, and how far the alcohol-use-disorder evidence actually goes.
10 questions · checked May 2026
Holidays, Restaurants and Vacations on a GLP-1: 10 Questions
Whether one big meal matters, why starting before Thanksgiving is a bad idea, what happens to buffets and restaurant portions, whether skipping a dose for vacation is worth it, and how to restart.
10 questions · checked May 2026
GLP-1 Reflux: 10 Questions About Heartburn, Acid and Aspiration Risk
Why these drugs cause reflux, how it differs from gastroparesis, whether antacids are enough, and the surgery question that genuinely matters, with the guideline and trial evidence behind each.
10 questions · checked May 2026
GLP-1 Nausea: 10 Questions About Managing It
How common nausea really is, why it comes back at every dose step, which anti-emetics and foods have evidence behind them, and the specific symptoms that mean stop waiting and call someone.
10 questions · checked May 2026
Training on a GLP-1: 10 Questions About Muscle, Cardio and Energy
What resistance training actually preserves, why cardio feels harder, how much protein the trials support, when in the injection week to train hard, and what the dizziness means.
10 questions · checked May 2026
GLP-1s With a Cancer History: 10 Questions, Answered by Site
Which cancer history actually rules these drugs out, what the human thyroid and pancreatic data show, whether survivors face a recurrence signal, and what to do about scopes and active treatment.
10 questions · checked May 2026
GLP-1s and Your Thyroid: 10 Questions About the Boxed Warning
Who the contraindication actually excludes, what the rodent data does and does not show, why your levothyroxine dose may shift, and whether the human cancer signal survives scrutiny.
10 questions · checked May 2026
GLP-1s With IBS, IBD or Gastroparesis: 10 Questions
Whether these drugs worsen IBS, what the IBD cohort data actually found, why pre-existing gastroparesis is the real red line, and how to tell drug side effects apart from a flare.
10 questions · checked May 2026
GLP-1s and Heart Failure: 10 Questions, Split by Ejection Fraction
Why HFpEF and HFrEF get opposite answers, what SUMMIT and STEP-HFpEF actually showed, what the heart-rate rise means on a beta-blocker, and why your diuretic dose will probably need revisiting.
10 questions · checked May 2026
"Ozempic Face" and Loose Skin: 10 Questions About Skin on a GLP-1
What the gaunt look actually is, whether loose skin is permanent, what slowing down changes, which cosmetic options have evidence, and when surgery becomes a reasonable conversation.
10 questions · checked May 2026
Questions are paraphrased from public forum threads. Answers summarize published trial data and FDA labeling and are not medical advice.